• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

October 2023 Labs in Court

October 2023 Labs in Court

by Glenn S. Demby | Sep 25, 2023 | Lab Compliance Advisor, Labs in Court

Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.

This content is for Paid Members only.
Login Register
DX Deals: Teaming with Google Leads to WGS Success for PacBio

DX Deals: Teaming with Google Leads to WGS Success for PacBio

by Glenn S. Demby | Aug 31, 2023 | Deals-lir, Laboratory Industry Report

A strategic partnership with Google enables more accurate whole genome sequencing with machine learning.

This content is for Paid Members only.
Login Register
What Are the Latest CFTR Carrier Screening Recommendations?

What Are the Latest CFTR Carrier Screening Recommendations?

by Beth Krietsch, MPH | Aug 29, 2023 | Diagnostic Testing and Emerging Technologies, Special Focus-dtet

New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.

This content is for Paid Members only.
Login Register
Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments

Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments

by Glenn S. Demby | Aug 24, 2023 | Enforcement-nir, National Lab Reporter

Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.

This content is for Paid Members only.
Login Register
Dx Deals: Exact Sciences Makes Big Moves to Maintain Leadership of Cancer DNA Testing Market

Dx Deals: Exact Sciences Makes Big Moves to Maintain Leadership of Cancer DNA Testing Market

by Glenn S. Demby | Aug 1, 2023 | Deals-lir, Laboratory Industry Report

Release of second-generation Cologuard test data and recently announced partnerships aim to position company well for the future.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com